Wendy future of retail top

merimepodib oral solution

FDA completes review investigational new drug application from BioSig

FDA completes review investigational new drug application from BioSig

WESTPORT, Conn.— BioSig Technologies announced that the U.S. Food and Drug Administration (FDA) has completed its review of ViralClear’s Investigational New Drug (IND) application. The FDA informed ViralClear that it may proceed with a proposed phase II study of merimepodib oral solution in adults with COVID-19 who are hospitalized and either require supplemental oxygen or

PP_1170x120_10-25-21